GDRXGoodRx Holdings, Inc.

$3.38-23% 1Y

Is it growing?

Watch

Growth is fading: earnings down −60% year on year and operating margin narrowing (−1.6 points).

2 to watch, 1 neutral
Revenue trend−2% in a year

Trailing-twelve-month revenue vs a year earlier, from the company's own filings. Five-year pace: +4% a year.

Earnings trend−60% in a year

Trailing-twelve-month earnings per share against a year earlier. Growing slower than revenue, so the growth is costing something.

Margin direction−1.6 points operating

Trailing-twelve-month operating margin, 9.5% now against 11.1% a year earlier.

All from SEC EDGAR, as of Jun 30, 2026.

Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.

Is GDRX growing?

GoodRx Holdings, Inc. has grown revenue 1.8% a year over three years and 4.5% a year over five, with earnings per share compounding at 26%.

+1.8%

Revenue growth, 3-year annual rate · Health Information Services median +10% · growing slowly · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate
+4.5%

Revenue growth, 5-year rate · +1.8% over three · growth has slowed since the five-year average

Earnings per share, 3-year rate
+26%

Earnings per share, 3-year rate · revenue +1.8% · earnings outgrew revenue: margins or the share count worked for shareholders

Years of annual history on file
8

Years of annual history on file · FY2018 to FY2025, as filed

Details›
Revenue FY2021
$745M
Revenue FY2022
$767M
Revenue FY2023
$750M
Revenue FY2024
$792M
Revenue FY2025
$797M

Annual income statements as filed with the SEC.